Perspective Therapeutics (CATX) Cash from Operations (2010 - 2026)

Perspective Therapeutics has disclosed Cash from Operations across 17 years of filings, most recently posting 31468000.0 for Q1 2026.

• Cash from Operations for Q1 2026 came in at 31468000.0, down 45.81% year-over-year; the trailing twelve-month figure through Mar 2026 was 92370000.0 (down 71.93% YoY), and the FY2025 annual result was 82484000.0, down 350.88% from the prior year.
• Cash from Operations came in at 31468000.0 for Q1 2026 at Perspective Therapeutics, down from 24657000.0 in the prior quarter.
• In the past five years, Cash from Operations ranged from a high of 13848000.0 in Q1 2024 to a low of 31468000.0 in Q1 2026.
• The 5-year median for Cash from Operations is 9008000.0 (2023), against an average of 10749823.53.
• Across the five-year window, Cash from Operations jumped 242.43% in 2024 and tumbled 584.02% in 2025, its largest moves.
• Perspective Therapeutics' Cash from Operations stood at 6086000.0 in 2022, then tumbled by 48.01% to 9008000.0 in 2023, then slumped by 195.36% to 26606000.0 in 2024, then climbed by 7.33% to 24657000.0 in 2025, then dropped by 27.62% to 31468000.0 in 2026.
• The last three Cash from Operations figures came in at 31468000.0 (Q1 2026), 24657000.0 (Q4 2025), and 16292000.0 (Q3 2025), per Business Quant data.